You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
The Company’s raison d'être is to contribute to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The Company aims to sustainably enhance enterprise value by being chosen and trusted by all stakeholders. With this business philosophy, we work to ensure and strengthen the effectiveness of corporate governance from the following perspectives:
The Company has established the Corporate Governance Guidelines which clarifies the basic views and guidelines of the Company’s corporate governance.
The summary of the corporate governance systems is as follows:
The Board of Directors specifies the skills, etc. (knowledge, experience, abilities, etc.) that should be possessed as a whole in order to properly perform its function in light of the Company’s corporate strategies.
The skills, etc. expected of Directors and the composition of advisory committees are as follows.
Corporate Strategy |
|
Risk Management |
|
Stakeholder Engagement |
|
Corporate Governance |
|
Board of Directors as a means of examining and improving issues to further enhance the effectiveness of the Board of Directors, and discloses a summary of the results thereof. For the analysis and evaluation of the effectiveness of the Board of Directors for the business year under review, an external evaluation organization was used to conduct a third-party evaluation based on a self-assessment questionnaire and interviews with all Directors. The Board of Directors discussed the results of the analysis based on those findings and made a final evaluation. Directors also provided each other with individual feedback through the questionnaire.
[Process for evaluation of the effectiveness of the Board of Directors in FY2024]
In FY2024, for the first time, an external evaluation organization conducted an anonymous survey for all Directors, as well as individual interviews with the Directors. The survey and interviews were conducted based on the following items.
The results of the analysis were shared at a Board of Directors meeting held in April 2025 to evaluate overall effectiveness and discuss policies and measures, particularly regarding the composition of the Board of Directors, to further improve effectiveness.
[Conclusion]
It was determined that the overall effectiveness of the Board of Directors is sufficiently ensured.
[Reasons for the conclusion and evaluation]
[Initiatives to raise the effectiveness]
The Board of Directors discussed and shared its recognition of issues and future approach regarding the following areas with room for further improvement. Through these initiatives, the Board of Directors will strive to further improve its effectiveness.
* Average score of other companies that contact the third-party evaluation organization to conduct evaluation
Please refer to the “Corporate Governance Report” for more detail about our corporate governance.